首页> 外文期刊>Journal of Infectious Diseases >A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus
【24h】

A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus

机译:对葡萄球菌肽聚糖的调节性白介素10响应阻止对金黄色葡萄球菌的Th1 / Th17适应性免疫。

获取原文
       

摘要

Toll-like receptor (TLR) 2 on antigen-presenting cells (APCs) enables these cells to recognize peptidoglycan-embedded lipopeptides and glycopolymers in the Staphylococcus aureus cell wall and mount an inflammatory response to this microbe. TLR2 signalling can also modulate immunity to S. aureus by inducing an interleukin (IL)–10 response in APCs. What determines the balance between proinflammatory and modulatory responses to S. aureus is unknown. We show that the modulatory IL-10 response preferentially occurs upon CD14- and CD36-independent TLR2 signaling, triggering PI3K activation, and is restricted to monocytes and monocyte-derived macrophages (MΦs). In contrast, monocyte-derived dendritic cells (DCs) produce mostly IL-12 and IL-23. The differential APC polarization induced by staphylococcal peptidoglycan translates into differential T helper responses: MΦs primarily trigger IL-10 and weak IL-17 responses, whereas DCs trigger a robust Th1/Th17 response. Exploitation of TLR2 signalling plasticity by S. aureus may explain the wide range of outcomes of human encounters with this microbe.
机译:抗原呈递细胞(APC)上的Toll样受体(TLR)2使这些细胞能够识别金黄色葡萄球菌细胞壁中包埋的肽聚糖包埋的脂肽和糖聚合物,并对这种微生物产生炎症反应。 TLR2信号传导还可通过在APC中诱导白介素(IL)-10应答来调节对金黄色葡萄球菌的免疫力。决定对金黄色葡萄球菌促炎反应和调节反应之间平衡的决定因素尚不清楚。我们表明,调节性IL-10响应优先出现在CD14和CD36独立的TLR2信号上,触发PI3K激活,并局限于单核细胞和单核细胞衍生的巨噬细胞(MΦs)。相反,单核细胞衍生的树突状细胞(DCs)主要产生IL-12和IL-23。由葡萄球菌肽聚糖诱导的差异APC极化转化为差异T辅助反应:MΦ主要触发IL-10和弱IL-17反应,而DC触发强大的Th1 / Th17反应。金黄色葡萄球菌对TLR2信号可塑性的利用可能解释了人类与这种微生物接触的广泛结果。

著录项

  • 来源
    《Journal of Infectious Diseases》 |2011年第2期|p.253-262|共10页
  • 作者单位

    The Centre for Human Immunology, Departments of Microbiology and Immunology, and Medicine, and Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada;

    The Centre for Human Immunology, Departments of Microbiology and Immunology, and Medicine, and Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada;

    The Centre for Human Immunology, Departments of Microbiology and Immunology, and Medicine, and Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada;

    The Centre for Human Immunology, Departments of Microbiology and Immunology, and Medicine, and Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada;

    The Centre for Human Immunology, Departments of Microbiology and Immunology, and Medicine, and Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 01:10:23

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号